1
|
Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patients. J Neural Transm (Vienna) 2020; 127:1185-1198. [PMID: 32519194 DOI: 10.1007/s00702-020-02214-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Accepted: 05/28/2020] [Indexed: 02/06/2023]
Abstract
Psychiatric patients are high-risk patients for the development of pharmacokinetic drug-drug interactions (DDIs), leading to highly variable (victim) drug serum concentrations. Avoiding and targeting high-risk drug combinations could reduce preventable adverse drug reactions (ADRs). Pharmacokinetic cytochrome P450 (CYP)-mediated DDIs are often predictable and, therefore, preventable. The retrospective, longitudinal analysis used informations from a large pharmacovigilance study (Optimization of pharmacological treatment in hospitalized psychiatric patients study, study number 01VSF16009, 01/2017), conducted in 10 psychiatric hospitals in Germany. Medication data were examined for the co-prescription of clinically relevant CYP inhibitors or inducers and substrates of these enzymes (victim drugs). In total, data from 27,396 patient cases (45.6% female) with a mean (mean ± standard deviation (SD)) age of 47.3 ± 18.3 years were available for analysis. CYP inhibitors or inducers were at least once prescribed in 14.4% (n = 3946) of the cases. The most frequently prescribed CYP inhibitors were melperone (n = 2504, 28.1%) and duloxetine (n = 1324, 14.9%). Overall, 51.0% of the cases taking melperone were combined with a victim drug (n = 1288). Carbamazepine was the most frequently prescribed CYP inducer (n = 733, 88.8%). Combinations with victim drugs were detected for 58% (n = 427) of cases on medication with carbamazepine. Finally, a DDI was detected in 43.6% of the cases in which a CYP inhibitor or inducer was prescribed. The frequency of CYP-mediated DDI is considerably high in the psychiatric setting. Physicians should be aware of the CYP inhibitory and inducing potential of psychotropic and internistic drugs (especially, melperone).
Collapse
|
2
|
Doran Z, Shankar R, Keezer MR, Dale C, McLean B, Kerr MP, Devapriam J, Craig J, Sander JW. Managing anti-epileptic drug treatment in adult patients with intellectual disability: a serious conundrum. Eur J Neurol 2016; 23:1152-7. [DOI: 10.1111/ene.13016] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Accepted: 03/02/2016] [Indexed: 11/28/2022]
Affiliation(s)
- Z. Doran
- Cornwall Partnership NHS Foundation Trust; Cornwall UK
| | - R. Shankar
- Cornwall Partnership NHS Foundation Trust; Cornwall UK
- Exeter Medical School; Truro UK
| | - M. R. Keezer
- NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London UK
| | - C. Dale
- Cornwall Partnership NHS Foundation Trust; Cornwall UK
| | | | | | - J. Devapriam
- Leicestershire Partnership NHS Trust; Leicester UK
| | - J. Craig
- Belfast Health and Social Care Trust; Belfast UK
| | - J. W. Sander
- NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London UK
- Stichting Epilepsie Instellingen Nederland (SEIN); Heemstede The Netherlands
- Epilepsy Society; Chalfont St Peter Buckinghamshire UK
| |
Collapse
|
3
|
Ladner TR, Morgan CD, Pomerantz DJ, Kennedy VE, Azar N, Haas K, Lagrange A, Gallagher M, Singh P, Abou-Khalil BW, Arain AM. Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experience. Epilepsia 2015; 56:e63-7. [PMID: 25809720 DOI: 10.1111/epi.12965] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/11/2015] [Indexed: 03/10/2024]
Abstract
In 2011, the American Academy of Neurology (AAN) established eight epilepsy quality measures (EQMs) for chronic epilepsy treatment to address deficits in quality of care. This study assesses the relationship between adherence to these EQMs and epilepsy-related adverse hospitalizations (ERAHs). A retrospective chart review of 475 new epilepsy clinic patients with an ICD-9 code 345.1-9 between 2010 and 2012 was conducted. Patient demographics, adherence to AAN guidelines, and annual number of ERAHs were assessed. Fisher's exact test was used to assess the relationship between adherence to guidelines (as well as socioeconomic variables) and the presence of one or more ERAH per year. Of the eight measures, only documentation of seizure frequency, but not seizure type, correlated with ERAH (relative risk [RR] 0.343, 95% confidence interval [CI] 0.176-0.673, p = 0.010). Among patients in the intellectually disabled population (n = 70), only review/request of neuroimaging correlated with ERAH (RR 0.128, 95% CI 0.016-1.009, p = 0.004). ERAHs were more likely in African American patients (RR 2.451, 95% CI 1.377-4.348, p = 0.008), Hispanic/Latino patients (RR 4.016, 95% CI 1.721-9.346, p = 0.016), Medicaid patients (RR 2.217, 95% CI 1.258-3.712, p = 0.009), and uninsured patients (RR 2.667, 95% CI 1.332-5.348, p = 0.013). In this retrospective series, adherence to the eight AAN quality measures did not strongly correlate with annual ERAH.
Collapse
Affiliation(s)
- Travis R Ladner
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Clinton D Morgan
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Daniel J Pomerantz
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Vanessa E Kennedy
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Nabil Azar
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Kevin Haas
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Andre Lagrange
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Martin Gallagher
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Pradumna Singh
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Bassel W Abou-Khalil
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| | - Amir M Arain
- Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A
| |
Collapse
|
4
|
Matson JL, Cervantes PE. Current status of the Matson Evaluation of Drug Side Effects (MEDS). RESEARCH IN DEVELOPMENTAL DISABILITIES 2013; 34:1849-1853. [PMID: 23528442 DOI: 10.1016/j.ridd.2013.02.030] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2013] [Accepted: 02/25/2013] [Indexed: 06/02/2023]
Abstract
The Matson Evaluation of Drug Side Effects (MEDS) is currently the best established and most researched measure of drug side effects in the intellectual disability (ID) literature. Initial research was conducted on its psychometric properties such as reliability and validity. More recent research studies have used the measure to determine the interactive effects of severity of drug side effects on adaptive and social behaviors as well as symptoms of commonly medicated psychiatric conditions among persons with ID. Most recently the MEDS has been used to study potential risk factors of psychotropic drugs. The present study was written to review the current status of MEDS research in the broader context of psychotropic drug side effect research in general.
Collapse
Affiliation(s)
- Johnny L Matson
- Department of Psychology, Louisiana State University, Baton Rouge, LA 70803, USA
| | | |
Collapse
|
5
|
Living environment of persons with severe epilepsy and intellectual disability: a prospective study. Epilepsy Behav 2009; 14:484-90. [PMID: 19162224 DOI: 10.1016/j.yebeh.2008.12.021] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2008] [Revised: 12/22/2008] [Accepted: 12/24/2008] [Indexed: 11/20/2022]
Abstract
We studied a population with intellectual disability (ID) and epilepsy and analyzed aspects of the living environment. Using an epilepsy impact score (EPIEK, the Epilepsy Impact Scale Kempenhaeghe), we found that epilepsy is more severe in younger persons than in older persons until about age 60 years. Individuals with more adaptive behavior had less severe epilepsy. Compared with persons with ID, the subjects in this study had fewer sensory problems and many more mobility problems, and more often saw a general practitioner. We concluded that people with severe epilepsy and ID have, in some ways, the same needs as people with only ID, and yet, in other ways (development of adaptive skills and aspects of living environment), distinctly different needs.
Collapse
|
6
|
van Blarikom W, Tan IY, Aldenkamp AP, van Gennep ATG. Epilepsy, intellectual disability, and living environment: a critical review. Epilepsy Behav 2006; 9:14-8. [PMID: 16714148 DOI: 10.1016/j.yebeh.2006.04.001] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2005] [Revised: 03/14/2006] [Accepted: 04/06/2006] [Indexed: 10/24/2022]
Abstract
Epilepsy occurs at a higher incidence and is more prevalent in people with an intellectual disability than in the general population. Nonetheless, we have insufficient knowledge of the extra needs of people with epilepsy and intellectual disability, of their families, and of the living environment. The lack of information about specific needs of the living environment may, in particular, be important. A Medline search revealed that scant attention has been paid to the specific needs for patients with epilepsy and intellectual disability, and only a few studies have focused specifically on this topic. The majority of studies have been focused on medical treatment issues and the organization and availability of health and social services. There is an indication that people with epilepsy and intellectual disability lack skills training appropriate to their intellectual potential. And although several reviews have emphasized the need for information on living environment and quality of life, we did not find such studies in our search.
Collapse
|